Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance

Journal of Immunology

Volumn 170, Issue 3, 2003, Pages 1304-1312

  Min, Wei Ping ^a,b,e   Zhou, Dejun ^f   Ichim, Thomas E ^f   Strejan, Gill H ^f   Xia, Xiaoping ^f   Yang, Jinming ^f   Huang, Xuyan ^c   Garcia, Bertha ^f   White, David ^c   Dutartre, Patrick ^d   Jevnikar, Anthony M ^a,b,c   Zhong, Robert ^a,b,c  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d Laboratoires Fournier SA   (France)

^e Tolero Tech   (Canada)

^f LHSC UC 9L9 ^*

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; LF 150195; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEEDBACK SYSTEM; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSPLANTATION;

EID: 0037307921     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.3.1304     Document Type: Article

References (52)

1. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182:18.
2. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99:3493.
3. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168:1080.
4. + T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment. J. Immunol. 168:5058.
5. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431.
6. Sanchez-Fueyo, A., M. Weber, C. Domenig, T. B. Strom, and X. X. Zheng. 2002. Tracking the immunoregulatory mechanisms active during allograft tolerance. J. Immunol. 168:2274.
7. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:301.
8. Mahnke, K., E. Schmitt, L. Bonifaz. A. H. Enk, and H. Jonuleit. 2002. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol. Cell Biol. 80:477.
9. Steinman, R. M., and M. C. Nussenzweig. 2002. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99:351.
10. Jonuleit, H., E. Schmitt, K. Steinbrink, and A. H. Enk. 2001. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22:394.
11. Thomson, A. W., and L. Lu. 1999. Dendritic cells as regulators of immune reactivity: implications for transplantation. Transplantation 68:1.
12. Morelli, A. E., H. Hackstein, and A. W. Thomson. 2001. Potential of tolerogenic dendritic cells for transplantation. Semin. Immunol. 13:323.
13. Rastellini, C., L. Lu, C. Ricordi, T. E. Starzl, A. S. Rao, and A. W. Thomson. 1995. Granulocyte/Macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 60:1366.
14. Fu, F., Y. Li, S. Qian, L. Lu, F. D. Chambers, T. E. Starzl, J. J. Fung, and A. W. Thomson. 1997. Costimulatory molecule-deficient dendritic cell progenitors induce T cell hyporesponsiveness in vitro and prolong the survival of vascularized cardiac allografts. Transplant. Proc. 29:1310.
15. Lu, L., W. Li, F. Fu, F. G. Chambers, S. Qian, J. J. Fung, and A. W. Thomson. 1997. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 64:1808.
16. Giannoukakis, N., C. A. Bonham, S. Qian, Z. Zhou, L. Peng, J. Hamaha, W. Li, A. W. Thomson, J. J. Fung, P. D. Robbins, and L. Lu. 2000. Prolongation of cardiac allograft survival using dendritic cells treated with NF-ΚB decoy oligodeoxyribonucleotides. Mol. Ther. 1:430.
17. Thomas, J. M., J. L. Contreras, X. L. Jiang, D. E. Eckhoff, P. X. Wang, W. J. Hubbard, A. L. Lobashevsky, W. Wang, C. Asiedu, S. Stavrou. et al. 1999. Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation 68:1660.
18. Hara, M., C. I. Kingsley, M. Niimi, S. Read, S. E. Turvey, A. R. Bushell, P. J. Morris, F. Powrie, and K. J. Wood. 2001. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166:3789.
19. Zhou, D., C. O'Brien, B. Garcia, P. Dutartre, G. H. Strejan, R. Zhong, and W.-P. Min. 2002. Tolerance induced by LF 15-0195, an analogue of 15-deoxyspergualine (DSG) is mediated by generation of suppressor dendritic cells. Am. J. Transplantation 2 (Suppl 3):162.
20. Roncarolo, M. G., M. K. Levings, and C. Traversari. 2001. Differentiation of T regulatory cells by immature dendritic cells. J. Exp. Med. 193:F5.
21. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30:1538.
22. + T cells can act as suppressor cells by affecting autologous dendritic cell conditioning and survival. J. Immunol. 168:1060.
23. Parry, N., A. I. Lazarovits, J. Wang, B. Garcia, P. Luke, S. Poppema, and R. Zhong. 1999. Cyclosporine inhibits long-term survival in cardiac allografts treated with monoclonal antibody against CD45RB. J. Heart Lung Transplant 18:441.
24. Min, W. P., R. Gorczynski, X. Y. Huang, M. Kushida, P. Kim, M. Obataki, J. Lei. R. M. Suri, and M. S. Cattral. 2000. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival. J. Immunol. 164:161.
25. Zhang, Z., L. Zhu, D. Quan, B. Garcia, N. Ozcay, J. Duff, C. Stiller, A. Lazarovits, D. Grant, and R. Zhong. 1996. Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation 62:1267.
26. Rothstein, D. M., M. F. Livak, K. Kishimoto, C. Ariyan, H. Y. Qian, S. Fecteau, M. Sho, S. Deng, X. X. Zheng, M. H. Sayegh, and G. P. Basadonna. 2001. Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models. J. Immunol. 166:322.
27. Lazarovits, A. I., S. Poppema, Z. Zhang, M. Khandaker, C. E. Le Feuvre, S. K. Singhal, B. M. Garcia, N. Ogasa, A. M. Jevnikar, M. H. White, et al. 1996. Prevention and reversal of renal allograft rejection by antibody against CD45RB. Nature 380:717.
28. Basadonna, G. P., L. Auersvald. C. Q. Khuong, X. X. Zheng, N. Kashio, D. Zekzer, M. Minozzo, H. Qian, L. Visser, A. Diepstra, et al. 1998. Antibodymediated targeting of CD45 isoforms: a novel immunotherapeutic strategy. Proc. Natl. Acad. Sci. USA 95:3821.
29. Luke, P. P., C. A. O'Brien, A. M. Jevnikar, and R. Zhong. 2001. Anti-CD45RB monoclonal antibody-mediated transplantation tolerance. Curr. Mol. Med. 1:533.
30. Wang, H., K. A. Hosiawa, W.-P. Min, B. Garcia, X. Zhang, X. Huang, D. J. Kelvin, and R. Zhong. 2002. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting. Am. J. Transplantation 2 (Suppl. 3):385.
31. Gregori, S., M. Casorati, S. Amuchastegui, S. Smiroldo, A. M. Davalli, and L. Adorini. 2001. Regulatory T cells induced by 1α,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167:1945.
32. Shevach, E. M. 2000. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18:423.
33. + Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16:183.
34. Woo, E. Y., H. Yeh, C. S. Chu, K. Schlienger, R. G. Carroll, J. L. Riley, L. R. Kaiser, and C. H. June. 2002. Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J. Immunol. 168:4272.
35. Thomson, A. W., L. Lu, N. Murase, A. J. Demetris, A. S. Rao, and T. E. Starzl. 1995. Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells 13:622.
36. Rifle, G., and C. Mousson. 2002. Dendritic cells and second signal blockade: a step toward allograft tolerance? Transptantation 73:S1.
37. Belz, G. T., W. R. Heath, and F. R. Carbone. 2002. The role of dendritic cell subsets in selection between tolerance and immunity. Immunol. Cell Biol. 80:463.
38. Lu, L., and A. W. Thomson. 2002. Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease. Transplantation 73:S19.
39. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189:587.
40. Thomson, A. W., M. L. Drakes, A. F. Zahorchak, P. J. O'Connell, R. J. Steptoe, S. Qian, and L. Lu. 1999. Hepatic dendritic cells: immunobiology and role in liver transplantation. J. Leukocyte Biol. 66:322.
41. Szabo, G., C. Gavala, and P. Mandrekar. 2001. Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells. J. Invest. Med. 49:442.
42. Lutz, M. B., R. M. Suri, M. Niimi, A. L. Ogilvie, N. A. Kukutsch, S. Rossner, G. Schuler, and J. M. Austyn. 2000. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur. J. Immunol. 30:1813.
43. Yoshimura, S., J. Bondeson, F. M. Brennan, B. M. Foxwell, and M. Feldmann. 2001. Role of NFΚB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI. Eur. J. Immunol. 31:1883.
44. high regulatory cells in human peripheral blood. J. Immunol. 167:1245.
45. Armant, M., M. N. Avice, P. Hermann, M. Rubio, M. Kiniwa, G. Delespesse, and M. Sarfati. 1999. CD47 ligation selectively down-regulates human interleukin 12 production. J. Exp. Med. 190:1175.
46. Chang, C. C., R. Ciubotariu, J. S. Manavalan, J. Yuan, A. I. Colovai, F. Piazza, S. Lederman, M. Colonna, R. Cortesini, R. Dalla-Favera, and N. Suciu-Foca. 2002. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immun. 3:237.
47. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193:1295.
48. Geissmann, F., P. Revy, A. Regnault, Y. Lepelletier, M. Dy, N. Brousse, S. Amigorena, O. Hermine, and A. Durandy. 1999. TGF-β1 prevents the noncognate maturation of human dendritic Langerhans cells. J. Immunol. 162:4567.
49. Steinbrink, K., M. Wolfl, H. Jonuleit, J. Knop, and A. H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:4772.
50. Oluwole, S. F., M. X. Jin, N. C. Chowdhury, K. Engelstad, O. A. Ohajekwe, and T. James. 1995. Induction of peripheral tolerance by intrathymic inoculation of soluble alloantigens: evidence for the role of host antigen-presenting cells and suppressor cell mechanism. Cell. Immunol. 162:33.
51. Ichikawa, N., A. J. Demetris, T. E. Starzl, Q. Ye, T. Okuda, H. J. Chun, K. Liu, Y. M. Kim, and N. Murase. 2000. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection. Liver Transpl. 6:686.
52. Yamada, A., A. Chandraker, T. M. Laufer, A. J. Gerth, M. H. Sayegh, and H. Auchincloss, Jr. 2001. Recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade. J. Immunol. 167:5522.